Melissa G. Lechner, MD, PhD

Congratulations to Kyleigh Kimbrell for her recognition at the 2025 ATA meeting for research excellence in thyroid autoimmunity and sex differences! This is a crucial area of study that needs more attention. wix.to/CRrSXo0 #WomenInSTEM @AmThyroidAssn @UCLAHealth

ENDO 2025 - Excited to collaborate with UCSF, USC, U Colorado, and UNC Chapel Hill on our multi-center trial aiming to tackle ICI-Diabetes. Innovation in cancer treatment is our goal! Read more: wix.to/M8Grg8F #CancerResearch #ICI

New research alert! We explore strategies to reverse checkpoint inhibitor diabetes in our latest publication. Insights on autoimmune side effects from cancer treatments await you! Check it out: wix.to/AEKj4c4 #uclaitox #CancerResearch #Diabetes

Trump hits NIH with ‘devastating’ freezes on meetings, travel, communications, and hiring | Science | AAAS science.org/content/articl…

UCLA is now an NIH Autoimmune Center of Excellence. This represents a significant milestone in our dedication to innovative research in autoimmunity and excited to be a part of this group. wix.to/UaWTWMh #UCLA #Autoimmunity

We are shutting down the labs and many are displaced. Grateful for our colleagues and friends during this challenging time at UCLA. 💙 wix.to/4Au3fAB

New research on IrAE mechanisms and risk factors at the 2024 SITC meeting, wix.to/MRpJGem

Jarod, Kyleigh, and Jaden excel at ATA Chicago 2024 @amos18 @AmThyroidAssn @UCLAHealth wix.to/4F8dAvv

Increased IRAEs in Breast Cancer Patients Treated with RANKL inhibitor Denosumab + Checkpoint Inhibitor - Podium talk at San Antonio Breast Cancer Symposium by Dr. LeVee @UCLA @AlexisLeVee @ Cityofhope @SABCSSanAntonio wix.to/e7qmcW5

Congratulations to Sarah and Nicole - Uncovering the pathogenesis and potential therapy for ICI-Diabetes at Endo Society this week.#Endo2024 wix.to/8rciuVB

Su-Lechner labs happy to be on winter break! wix.to/ykyAwCq

Can't wait to read this - always insightful work from the Landa Lab

Shedding new light on the dark side of cancer immunotherapy - mechanisms of IRAEs. Just out in @ScienceTM, grateful for support from @UCLAHealth and @AmThyroidAssn and my collaborators @DoctorAngell @MaureenSuLab wix.to/yPSqMbG

@UCLAHealth Thrilled to be able to have collaborated with this group on an important study for patients living with HIV and ensuring these cancer treatments are available and safe for everyone. Read it here: ascopubs.org/doi/pdf/10.120…

1/25. Our work out in @JCO_ASCO! Real-world report from the CATCH-IT consortium. Fortunate to share this journey w/ co-authors, co-first authors @adib_Elio, @TalalZarif1 and under the mentorship of #naqashlab @sonpavde! @YaleCancer, @DanaFarberNews@YaleIMed. Tweetorial below:

Tackling checkpoint inhibitor endocrine autoimmune toxicities with great colleagues at the @fredhutch - youtube.com/watch?v=8U3eBl…

Check it out from Dr. Willy Hugo @UCLA New insights into anti-PD1 response in melanoma: Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors biorxiv.org/content/10.110…

Great to see my dear medical school friend @AlexisEDixonMD being awesome! Wouldn’t trust anyone else with my precious runner feet. laweekly.com/the-heal-insti…